Legend Biotech (納斯達克代碼: LEGN) 公布季度每股虧損為$(0.16)，優於分析師一致預期的$(0.33)，超出51.52%。與去年同期每股虧損$(0.24)相比，提高了33.33%。公司報告季度銷售額為$1.8652億，優於分析師一致預期的$1.7893億，超出4.24%。與去年同期的銷售額$7946萬相比，提高了134.73%。

以上內容來自Benzinga Earnings專欄，原文如下：

Legend Biotech (NASDAQ:LEGN) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.33) by 51.52 percent. This is a 33.33 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $186.52 million which beat the analyst consensus estimate of $178.93 million by 4.24 percent. This is a 134.73 percent increase over sales of $79.46 million the same period last year.